monitoring the aggressive drug regimens your patients are taking for rheumatoid arthritis

July 2012

You'll see more emphasis on monitoring the aggressive drug regimens your patients are taking for rheumatoid arthritis.

These patients often end up on multiple meds to prevent joint damage...reduce disability...and improve long-term outcomes.

But these aggressive combinations of disease-modifying antirheumatic drugs (DMARDs) need to be closely watched.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote